Aprepitant Intravenous and Rituximab and Hyaluronidase
Determining the interaction of Aprepitant Intravenous and Rituximab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Intravenous-Rituximab and hyaluronidase human, recombinant Subcutaneous
- Aprepitant Intravenous-Rituximab Intravenous
- Aprepitant Intravenous-Riva-Amoxicillin
- Aprepitant Intravenous-Rivaroxaban
- Aprepitant Intravenous-Rivastigmine
- Aprepitant Intravenous-Rivastigmine Capsules
- Rituximab and Hyaluronidase-Aprepitant Oral Suspension
- Rituximab and Hyaluronidase-Aprepitant/Fosaprepitant Dimeglumine
- Rituximab and Hyaluronidase-Apresazide
- Rituximab and Hyaluronidase-Apresoline
- Rituximab and Hyaluronidase-Apresoline Injection
- Rituximab and Hyaluronidase-Apri